6 stories found
Brazil has downgraded diplomatic relations with Argentina and recalled its ambassador after Argentine President Javier Milei made insulting remarks about Brazilian President Luiz Inácio Lula da Silva. This move escalates a diplomatic crisis between the two South American nations.
Apnimed, a biotech company supported by Shionogi and focused on a pill for sleep apnea, successfully raised $192 million in its U.S. Initial Public Offering.
Isao Teshirogi, President and CEO of Shionogi & Co, stated the company is actively pursuing at least three M&A deals and plans to establish more manufacturing sites in the US over the next decade.
Apnimed Inc., a late-stage drug developer specializing in sleep apnea treatments and backed by Shionogi, is aiming to raise up to $160 million through an initial public offering in the United States.
Several Japanese companies, including Mitsubishi Motors, Otsuka Corporation, and Shionogi & Co., have reported their latest GAAP EPS and revenue figures, with some reaffirming or updating their future outlooks.
A study has shown that Shionogi's oral antiviral pill successfully prevents COVID-19 infection after household exposure, marking a significant late-stage success for such a treatment.